These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cascade plasma filtration during the first year after CABG in patients with hyperlipidemia refractory to statins. Ezhov MV; Il'ina LN; Safarova MS; Afanasieva OI; Adamova IY; Atanesyan RV; Konovalov GA; Akchurin RS; Pokrovsky SN Atheroscler Suppl; 2013 Jan; 14(1):101-5. PubMed ID: 23357150 [TBL] [Abstract][Full Text] [Related]
5. Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial. Nicholls SJ; Puri R; Ballantyne CM; Jukema JW; Kastelein JJP; Koenig W; Wright RS; Kallend D; Wijngaard P; Borgman M; Wolski K; Nissen SE JAMA Cardiol; 2018 Sep; 3(9):806-814. PubMed ID: 30046837 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of non-culprit plaque regression following acute coronary syndrome: A serial intravascular ultrasound study. Endo H; Dohi T; Miyauchi K; Kuramitsu S; Kato Y; Okai I; Yokoyama M; Yokoyama T; Ando K; Okazaki S; Shimada K; Suwa S; Daida H J Cardiol; 2019 Aug; 74(2):102-108. PubMed ID: 30737184 [TBL] [Abstract][Full Text] [Related]
7. The effect of statin therapy on plaque regression following acute coronary syndrome: a meta-analysis of prospective trials. Tang X; Yang Y; Luo S; Zhao Y; Lu C; Luo Y; Zhang F; Xiao H Coron Artery Dis; 2016 Dec; 27(8):636-649. PubMed ID: 27388482 [TBL] [Abstract][Full Text] [Related]
16. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN; JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776 [TBL] [Abstract][Full Text] [Related]
17. Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology. Kovarnik T; Chen Z; Mintz GS; Wahle A; Bayerova K; Kral A; Chval M; Kopriva K; Lopez J; Sonka M; Linhart A Cardiovasc Diabetol; 2017 Dec; 16(1):156. PubMed ID: 29212544 [TBL] [Abstract][Full Text] [Related]
18. Effect of More Intensive LDL-C-Lowering Therapy on Long-term Cardiovascular Outcomes in Early-Phase Acute Coronary Syndrome: A Systematic Review and Meta-analysis. Jin S; Nie X; Li Y; Yuan J; Cui Y; Zhao L Clin Ther; 2021 Jul; 43(7):e217-e229. PubMed ID: 34092409 [TBL] [Abstract][Full Text] [Related]
19. Decreased circulating lipoprotein-associated phospholipase A2 levels are associated with coronary plaque regression in patients with acute coronary syndrome. Dohi T; Miyauchi K; Okazaki S; Yokoyama T; Ohkawa R; Nakamura K; Yanagisawa N; Tsuboi S; Ogita M; Yokoyama K; Kurata T; Yatomi Y; Daida H Atherosclerosis; 2011 Dec; 219(2):907-12. PubMed ID: 22024276 [TBL] [Abstract][Full Text] [Related]
20. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]